melphalan (low-dose)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for melphalan (low-dose), covering 2013-07-22 to 2013-07-22. Get the full timeline:
Most recent: Clinical Trial Update: Low Dose Melphalan and Bortezomib for AML and High-Risk MDS [NA]